The Stockholm Stock Exchange opened the week positively, with AB Volvo leading the OMXS30 index. However, the market faced pressure later in the day, closing down 0.4% as U.S. market trends weighed on investor sentiment. Notable declines included ABB, which fell amid rumors involving Microsoft, while Saab reached a new record high. On February 25, the market showed resilience, with the OMXS30 recovering to a 0.4% increase, bolstered by strong performance from Saab, despite mixed results from other stocks. Telia experienced gains following a large sale, but Carnegie's recommendation halted its upward momentum. In the biotech sector, BridgeBio Pharmaceuticals announced a $500 million convertible notes offering, leading to a pre-market decline of 5.1%. Meanwhile, Bonesupport reported a 15% increase in stock value after announcing over 40% organic growth guidance for 2025. Biotage's stock fell over 20% after disappointing fourth-quarter results, prompting discussions about potential buying opportunities.